GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 348 filers reported holding GLOBUS MED INC in Q4 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,915 | +27.0% | 78,857 | +52.3% | 0.03% | +32.0% |
| Q2 2023 | $3,082 | -0.2% | 51,765 | -5.1% | 0.02% | -3.8% |
| Q1 2023 | $3,088 | -26.3% | 54,525 | -3.4% | 0.03% | -29.7% |
| Q4 2022 | $4,191 | -99.9% | 56,429 | +1.8% | 0.04% | +15.6% |
| Q3 2022 | $3,302,000 | +3.9% | 55,427 | -2.1% | 0.03% | +6.7% |
| Q2 2022 | $3,177,000 | -23.2% | 56,593 | +0.9% | 0.03% | -6.2% |
| Q1 2022 | $4,138,000 | -50.4% | 56,079 | -51.5% | 0.03% | +3.2% |
| Q4 2021 | $8,346,000 | +92.0% | 115,584 | +103.7% | 0.03% | -16.2% |
| Q3 2021 | $4,348,000 | -9.7% | 56,752 | -8.6% | 0.04% | -5.1% |
| Q2 2021 | $4,816,000 | +728.9% | 62,113 | +559.0% | 0.04% | +77.3% |
| Q1 2021 | $581,000 | -11.3% | 9,426 | -6.1% | 0.02% | -12.0% |
| Q4 2020 | $655,000 | +34.2% | 10,043 | +1.9% | 0.02% | +19.0% |
| Q3 2020 | $488,000 | +3.4% | 9,851 | -0.4% | 0.02% | -4.5% |
| Q2 2020 | $472,000 | -22.4% | 9,894 | -30.8% | 0.02% | +46.7% |
| Q1 2020 | $608,000 | -30.2% | 14,305 | -3.3% | 0.02% | -6.2% |
| Q4 2019 | $871,000 | +20.6% | 14,789 | +4.8% | 0.02% | +6.7% |
| Q3 2019 | $722,000 | +19.1% | 14,116 | -1.5% | 0.02% | +7.1% |
| Q2 2019 | $606,000 | +3.9% | 14,334 | +21.5% | 0.01% | 0.0% |
| Q1 2019 | $583,000 | +18.0% | 11,801 | +3.4% | 0.01% | 0.0% |
| Q4 2018 | $494,000 | +73.9% | 11,418 | +128.5% | 0.01% | +100.0% |
| Q3 2018 | $284,000 | -51.9% | 4,998 | -57.2% | 0.01% | -50.0% |
| Q2 2018 | $590,000 | +16.6% | 11,684 | +15.1% | 0.01% | +7.7% |
| Q1 2018 | $506,000 | +19.1% | 10,153 | -1.8% | 0.01% | +18.2% |
| Q4 2017 | $425,000 | +47.1% | 10,337 | +6.3% | 0.01% | +22.2% |
| Q3 2017 | $289,000 | -14.2% | 9,721 | -4.3% | 0.01% | -18.2% |
| Q2 2017 | $337,000 | +17.8% | 10,162 | +5.3% | 0.01% | -21.4% |
| Q1 2017 | $286,000 | +19.2% | 9,651 | -0.1% | 0.01% | +27.3% |
| Q4 2016 | $240,000 | – | 9,663 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |